Mehrdad Arjomandi, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
Phone415-221-4810 ext. 24393
ORCID ORCID Icon0000-0002-0116-9217 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San DiegoBA06/1991Molecular Biology
    Stanford UniversityMD06/1996MD Program
    University of California, Los AngelesResidency06/1999Internal Medicine
    University of California, San FranciscoFellowship06/2003Pulmonary & Critical Care Medicine
    University of California, San FranciscoCertificate06/2003Advanced Training in Clinical Research
    Veterans Affairs Cooperative Study ProgramCertificate08/2009Clinical Trial Design Course
    University of California, San FranciscoCertificate05/2010Mentor Development Program
    The Jackson Laboratories (NIH/NHLBI)Certificate10/2010Genetic Approaches to Complex Heart, Lung and Blood Diseases
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    Dr. Arjomandi grew up in Ahvaz, a small city in Southwestern Iran, and moved to the United States in 1986 in the aftermath of Iranian revolution (1979), Iraq invasion of Iran (1980-88), and his family displacement inside Iran (1980-83). When in California, he began his higher education at Los Angeles Pierce College before transferring to University of California San Diego in 1988, where he obtained a bachelor degree in molecular biology and completed a senior honors thesis in developmental biology in Dr. Richard Firtel’s lab. He then attended Stanford University School of Medicine in 1991, completing two predoctoral research fellowships in Dr. Etienne Emile Beaulieu’s lab at INSERM in Paris, France, and Dr. John Cooke’s vascular biology lab at Stanford. Dr. Arjomandi then completed a residency in internal medicine at UCLA (1996-99) and a fellowship in pulmonary and critical care at UCSF (2000-03). He completed three additional years of research fellowship funded by the American Lung Association and Chest Foundation before successfully competing for an NIH K23 award in 2006 and then joining the pulmonary and critical care faculty at UCSF and San Francisco General Hospital (SFGH). In 2008, he obtained a joint appointment at San Francisco VA Medical Center (SF VA).

    Currently, Dr. Arjomandi is Professor of Medicine in the Divisions of Pulmonary, Critical Care, Allergy, and Sleep Medicine and Occupational and Environmental Medicine at UCSF with a joint appointment at SF VA. He is Director of the UCSF Human Exposure Laboratory at SFGH, Director of Environmental Medicine Clinic at SF VA, Site Director for the SF VA Airborne Hazard Exposure Study Center of Excellence, an investigator at the UCSF Center for Tobacco Control Research and Education, and a member of the UCSF Helen Diller Family Comprehensive Cancer Center.

    Research Interests

    The lung is constantly exposed to various environmental pollutants, allergens, and toxins, which interact with airways and alveoli and result in inflammation, injury, and disease. My laboratory primary research interest has been centered on the paradigm that respiratory exposures to pollutants and toxicants contribute to development and progression of chronic lung diseases, and may further yield systemic effects well beyond lungs. Under this paradigm, my research activities have focused on understanding the physiologic and immunologic mechanisms via which environmental exposures contribute to chronic lung diseases and how knowledge of these mechanisms could be translated to ways to better define, prognosticate, and manage disease burden at both individual and societal levels.

    I have dedicated my efforts to (1) investigate the biology of airway immune cells using inhalational exposure to ozone in humans as a model of lung injury simulating exacerbation in chronic lung disease, and (2) characterize the early cardiopulmonary changes due to exposure to tobacco smoke and the pathophysiology and biology associated with those changes.

    Collapse Research 
    Collapse Research Activities and Funding
    Modulation of COVID-19 by Smoking: The Basis for a Clinical Trial
    Department of Veterans Affairs PendingOct 1, 2020 - Jun 30, 2021
    Role: PI
    Clinical Feasibility of a Non-Invasive Wearable Acoustic Device for Measuring Air Trapping in COPD
    NIH 1 R41 HL152769-01A1Jul 20, 2020 - Jun 30, 2021
    Role: Sub-Award PI
    Occult Cardiovascular Disease with Chronic Exposure to Secondhand Tobacco Smoke
    Flight Attendant Medical Research Institute (FAMRI) SFGH FoundationJul 1, 2020 - Jun 30, 2023
    Role: PI
    Lung Macrophage Populations and Functions in COPD-Susceptible Smokers (Pre-COPD Study)
    Department of Defense W81XWH-20-1-0158Mar 1, 2020 - Feb 28, 2022
    Role: PI
    Characterization of Innate Immunity in Pollution-induced Exacerbation in Chronic Obstructive Pulmonary Disease (CO3PD Study)
    California TRDRP T29IR0715Apr 1, 2019 - Mar 31, 2022
    Role: PI
    Circulating Tumor DNA in Patients at High Risk for Lung Cancer
    Guardant Health, Inc. NCIRE-2062Jul 1, 2017 - Jun 30, 2022
    Role: PI
    Lung Tissue Macrophages in Chronic Obstructive Pulmonary Disease (COPD)
    GlaxoSmithKline Inc. NCIRE- 1961Jan 1, 2016 - Dec 31, 2017
    Role: PI
    Lung Health Effects of Chronic Exposure to Secondhand Tobacco Smoke
    Flight Attendant Medical Research Institute (FAMRI) SFGH FoundationJul 1, 2015 - Jun 30, 2021
    Role: PI
    Characterization of Innate Immune Dysfunction in Chronic Obstructive Pulmonary Disease (COPD)
    Five Prime Therapeutics, Inc. NCIRE #1766Oct 1, 2012 - Jun 30, 2016
    Role: PI
    Osteopontin in Oxidative Injury and Airway Remodeling in Asthma
    NIH K23HL083099Sep 1, 2006 - Jun 30, 2012
    Role: PI

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Faculty Mentoring
    Collapse Academic Senate

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lung Immune Tone via Gut-Lung Axis: Gut-derived LPS and Short-chain Fatty Acids' immunometabolic regulation of Lung IL-1ß, FFAR2 and FFAR3 Expression. Am J Physiol Lung Cell Mol Physiol. 2021 Apr 14. Liu Q, Tian X, Maruyama D, Arjomandi M, Prakash A. PMID: 33851870.
      View in: PubMed   Mentions:    Fields:    
    2. Ratio of FEV1 to Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function. Chest. 2021 Feb 01. Fortis S, Comellas A, Bhatt SP, Hoffman EA, Han MK, Bhakta NR, Paine R, Ronish B, Kanner RE, Dransfield M, Hoesterey D, Buhr RG, Barr RG, Dolezal B, Ortega VE, Drummond MB, Arjomandi M, Kaner RJ, Kim V, Curtis JL, Bowler RP, Martinez F, Labaki WW, Cooper CB, O'Neal WK, Criner G, Hansel NN, Krishnan JA, Woodruff P, Couper D, Tashkin D, Barjaktarevic I. PMID: 33539837.
      View in: PubMed   Mentions:    Fields:    
    3. Lower PDL1, PDL2, and AXL Expression on Lung Myeloid Cells Suggests Inflammatory Bias in Smoking and Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol. 2020 12; 63(6):780-793. Vasudevan S, Vásquez JJ, Chen W, Aguilar-Rodriguez B, Niemi EC, Zeng S, Tamaki W, Nakamura MC, Arjomandi M. PMID: 32915645.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Do Ambient Ozone or Other Pollutants Modify Effects of Controlled Ozone Exposure on Pulmonary Function? Ann Am Thorac Soc. 2020 05; 17(5):563-572. Rich DQ, Thurston SW, Balmes JR, Bromberg PA, Arjomandi M, Hazucha MJ, Alexis NE, Ganz P, Zareba W, Thevenet-Morrison K, Koutrakis P, Frampton MW. PMID: 32125874.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    5. Military Burn Pits. Am J Respir Crit Care Med. 2020 04 01; 201(7):P13-P14. Sotolongo A, Falvo M, Santos S, Johnson I, Arjomandi M, Hines S, Krefft S, Osterholzer J. PMID: 32233853.
      View in: PubMed   Mentions:    Fields:    
    6. Multicenter Ozone Study in oldEr Subjects (MOSES): Part 2. Effects of Personal and Ambient Concentrations of Ozone and Other Pollutants on Cardiovascular and Pulmonary Function. Res Rep Health Eff Inst. 2020 Mar; (192, Pt 2):1-90. Rich DQ, Frampton MW, Balmes JR, Bromberg PA, Arjomandi M, Hazucha MJ, Thurston SW, Alexis NE, Ganz P, Zareba W, Koutrakis P, Thevenet-Morrison K. PMID: 32239870.
      View in: PubMed   Mentions:    Fields:    Translation:CTClinical Trials
    7. Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2020 02; 7(1). Blagev DP, Collingridge DS, Rea S, Carey KA, Mularski RA, Zeng S, Arjomandi M, Press VG. PMID: 32060034.
      View in: PubMed   Mentions:
    8. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis. Int J Chron Obstruct Pulmon Dis. 2019; 14:2927-2938. Barjaktarevic IZ, Buhr RG, Wang X, Hu S, Couper D, Anderson W, Kanner RE, Paine Iii R, Bhatt SP, Bhakta NR, Arjomandi M, Kaner RJ, Pirozzi CS, Curtis JL, O'Neal WK, Woodruff PG, Han MK, Martinez FJ, Hansel N, Wells JM, Ortega VE, Hoffman EA, Doerschuk CM, Kim V, Dransfield MT, Drummond MB, Bowler R, Criner G, Christenson SA, Ronish B, Peters SP, Krishnan JA, Tashkin DP, Cooper CB, NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) . PMID: 31908441.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS. Eur Respir J. 2019 10; 54(4). Arjomandi M, Zeng S, Barjaktarevic I, Barr RG, Bleecker ER, Bowler RP, Buhr RG, Criner GJ, Comellas AP, Cooper CB, Couper DJ, Curtis JL, Dransfield MT, Han MK, Hansel NN, Hoffman EA, Kaner RJ, Kanner RE, Krishnan JA, Paine R, Peters SP, Rennard SI, Woodruff PG, SPIROMICS Investigators . PMID: 31439683.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES). PLoS One. 2019; 14(9):e0222601. Balmes JR, Arjomandi M, Bromberg PA, Costantini MG, Dagincourt N, Hazucha MJ, Hollenbeck-Pringle D, Rich DQ, Stark P, Frampton MW. PMID: 31553765.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    11. Inflammatory Phenotypes Associated with Chronic Obstructive Pulmonary Disease Increase Susceptibility to Exacerbation. Lessons from Single Cell Analysis of Lung Macrophages. Ann Am Thorac Soc. 2018 Dec; 15(Supplement_4):S289. Vasudevan S, Vasquez J, Chen W, Zeng S, Arjomandi M. PMID: 30759013.
      View in: PubMed   Mentions:
    12. Back to the Box: Using Lung Volumes to Predict Susceptibility to Develop Chronic Obstructive Pulmonary Disease among Smokers. Ann Am Thorac Soc. 2018 Dec; 15(Supplement_4):S286-S287. Zeng S, Tham A, Bos B, Jin J, Arjomandi M. PMID: 30759017.
      View in: PubMed   Mentions:
    13. Analytical validation of a novel multi-analyte plasma test for lung nodule characterization. Biomedical research and reviews. 2018 November 23; 2. 2018; (2). Trivedi NN, Brown JK, Rubenstein T, Rostykus AD, Fish AL, Heng Y, Luis C, Alice J, Sandy K, Bhavin P, Sidhu M, Vuong D, Wang S, Beggs M, Wu AH, Arjomandi M. . View Publication.
    14. Analytical validation of a novel multi-analyte plasma test for lung nodule characterization. Biomed Res Rev. 2018 Dec; 2(3). Trivedi NN, Brown JK, Rubenstein T, Rostykus AD, Fish AL, Yu H, Carbonell L, Juang A, Kamer S, Patel B, Sidhu M, Vuong D, Wang S, Beggs M, Wu AH, Arjomandi M. PMID: 32923944.
      View in: PubMed   Mentions:
    15. Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assay. Biomed Res Clin Pract. 2018 Dec; 3(4). Trivedi NN, Arjomandi M, Brown JK, Rubenstein T, Rostykus AD, Esposito S, Axler E, Beggs M, Yu H, Carbonell L, Juang A, Kamer S, Patel B, Wang S, Fish AL, Haddad Z, Wu AH. PMID: 32913898.
      View in: PubMed   Mentions:
    16. Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assay. Biomedical research and clinical practice. Biomedical research and clinical practice. 2018; (3). Trivedi NN, Arjomandi M, Brown JK, Rubenstein T, Rostykus AD, Esposito S, Axler E, Beggs M, Yu H, Carbonell L, Juang A, Kamer S, Patel B, Wang S, Fish AL, Haddad Z, Wu AH. View Publication.
    17. MA23.03 Risk Assessment for Indeterminate Pulmonary Nodules Using a Novel, Plasma-Protein Based Biomarker Assay. Journal of Thoracic Oncology. 2018 Oct 1; 13(10):s439. A. Fish, A. Vachani, M. Beggs, L. Carbonell, Z. Haddad, A. Juang, S. Kamer, B. Patel, H. Yu, A. Wu, P. Massion, M. Arjomandi, J. Brown, N. Trivedi, T. Rubenstein. .
      View in: Publisher Site   Mentions:
    18. E-cigarettes versus nicotine patches for perioperative smoking cessation: a pilot randomized trial. PeerJ. 2018; 6:e5609. Lee SM, Tenney R, Wallace AW, Arjomandi M. PMID: 30280019.
      View in: PubMed   Mentions:
    19. Lung volume indices predict morbidity in smokers with preserved spirometry. Thorax. 2019 02; 74(2):114-124. Zeng S, Tham A, Bos B, Jin J, Giang B, Arjomandi M. PMID: 30030304.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    20. Cardiovascular function and ozone exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES). Environ Int. 2018 10; 119:193-202. Rich DQ, Balmes JR, Frampton MW, Zareba W, Stark P, Arjomandi M, Hazucha MJ, Costantini MG, Ganz P, Hollenbeck-Pringle D, Dagincourt N, Bromberg PA. PMID: 29980042.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    21. Marijuana Use, Respiratory Symptoms, and Pulmonary Function: A Systematic Review and Meta-analysis. Ann Intern Med. 2018 07 17; 169(2):106-115. Ghasemiesfe M, Ravi D, Vali M, Korenstein D, Arjomandi M, Frank J, Austin PC, Keyhani S. PMID: 29971337.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    22. Stability of Frequency of Severe Chronic Obstructive Pulmonary Disease Exacerbations and Health Care Utilization in Clinical Populations. Chronic Obstr Pulm Dis. 2018 Jun 20; 5(3):208-220. Blagev DP, Collingridge DS, Rea S, Press VG, Churpek MM, Carey K, Mularski RA, Zeng S, Arjomandi M. PMID: 30584584.
      View in: PubMed   Mentions:
    23. The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk. Front Med (Lausanne). 2018; 5:173. Blagev DP, Collingridge DS, Rea S, Horne BD, Press VG, Churpek MM, Carey KA, Mularski RA, Zeng S, Arjomandi M. PMID: 29942803.
      View in: PubMed   Mentions:
    24. Respiratory Responses to Ozone Exposure. MOSES (The Multicenter Ozone Study in Older Subjects). Am J Respir Crit Care Med. 2018 05 15; 197(10):1319-1327. Arjomandi M, Balmes JR, Frampton MW, Bromberg P, Rich DQ, Stark P, Alexis NE, Costantini M, Hollenbeck-Pringle D, Dagincourt N, Hazucha MJ. PMID: 29232153.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    25. Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction. BMJ Open Respir Res. 2018; 5(1):e000284. Arjomandi M, Zeng S, Geerts J, Stiner RK, Bos B, van Koeverden I, Keene J, Elicker B, Blanc PD, Gold WM. PMID: 29755755.
      View in: PubMed   Mentions:
    26. Increasing the Resolution of Chronic Obstructive Pulmonary Disease Definition. Lessons from a Cohort with Remote but Extensive Exposure to Secondhand Tobacco Smoke. Ann Am Thorac Soc. 2018 Apr; 15(Supplement_2):S122-S123. Arjomandi M, Zeng S, Blanc PD, Gold WM. PMID: 29676628.
      View in: PubMed   Mentions:
    27. Diagnosing Chronic Obstructive Pulmonary Disease Among Afghanistan and Iraq Veterans: Veterans Affair's Concordance With Clinical Guidelines for Spirometry Administration. Mil Med. 2017 09; 182(9):e1993-e2000. Schneiderman AI, Dougherty DD, Fonseca VP, Wolters CL, Bossarte RM, Arjomandi M. PMID: 28885968.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Modeling vascular inflammation and atherogenicity after inhalation of ambient levels of ozone: exploratory lessons from transcriptomics. Inhal Toxicol. 2017 02; 29(3):96-105. Tham A, Lullo D, Dalton S, Zeng S, van Koeverden I, Arjomandi M. PMID: 28412860.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    29. Asthma-COPD Overlap Syndrome- an Underdiagnosed Phenotype in Heavy Smokers. Journal of Allergy and Clinical Immunology. 2016 Feb 1; 137(2):ab102. Miren Guenechea-Sola, Sarah Dalton, Jeroen Geerts, Siyang Zeng, Mehrdad Arjomandi. .
      View in: Publisher Site   Mentions:
    30. Inflammatory and repair pathways induced in human bronchoalveolar lavage cells with ozone inhalation. PLoS One. 2015; 10(6):e0127283. Leroy P, Tham A, Wong H, Tenney R, Chen C, Stiner R, Balmes JR, Paquet AC, Arjomandi M. PMID: 26035830.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    31. Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects. . 2015 Jun 15; 308(12):H1499-509. Arjomandi M, Wong H, Donde A, Frelinger J, Dalton S, Ching W, Power K, Balmes JR. PMID: 25862833.
      View in: PubMed   Mentions:
    32. Ozone inhalation leads to a dose-dependent increase of cytogenetic damage in human lymphocytes. Environ Mol Mutagen. 2015 May; 56(4):378-87. Holland N, Davé V, Venkat S, Wong H, Donde A, Balmes JR, Arjomandi M. PMID: 25451016.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    33. IQGAP1-dependent scaffold suppresses RhoA and inhibits airway smooth muscle contraction. J Clin Invest. 2014 Nov; 124(11):4895-8. Bhattacharya M, Sundaram A, Kudo M, Farmer J, Ganesan P, Khalifeh-Soltani A, Arjomandi M, Atabai K, Huang X, Sheppard D. PMID: 25271629.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    34. Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis. COPD. 2015 04; 12(2):182-9. van Koeverden I, Blanc PD, Bowler RP, Arjomandi M. PMID: 24983136.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    35. Hidden Costs of Climate Change: Contribution of Ozone to Human Diseases. Proceedings of the American Association for the Advancement of Science. Proceedings of the U.S.-Iran Symposium on Air Pollution in Megacities. 2013. View Publication.
    36. Mfge8 suppresses airway hyperresponsiveness in asthma by regulating smooth muscle contraction. Proc Natl Acad Sci U S A. 2013 Jan 08; 110(2):660-5. Kudo M, Khalifeh Soltani SM, Sakuma SA, McKleroy W, Lee TH, Woodruff PG, Lee JW, Huang K, Chen C, Arjomandi M, Huang X, Atabai K. PMID: 23269839.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    37. Oxidative Injury Due to Inhalation of Ozone Causes Dose-Dependent Cytogenetic Damage in Peripheral Blood Lymphocytes. Annals of the American Thoracic Society. 2012 May 1; 9(2):81-82. Mehrdad Arjomandi, Subha Venkat, Hofer Wong, Aneesh Donde, John Balmes, Nina Holland. .
      View in: Publisher Site   Mentions:
    38. Reduced exercise tolerance and pulmonary capillary recruitment with remote secondhand smoke exposure. PLoS One. 2012; 7(4):e34393. Arjomandi M, Haight T, Sadeghi N, Redberg R, Gold WM. PMID: 22493689.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    39. Effects of exercise on systemic inflammatory, coagulatory, and cardiac autonomic parameters in an inhalational exposure study. J Occup Environ Med. 2012 Apr; 54(4):466-70. Donde A, Wong H, Frelinger J, Power K, Balmes JR, Arjomandi M. PMID: 22418276.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    40. Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Related Phenotypes in a Puerto Rican Population. Pediatr Allergy Immunol Pulmonol. 2011 Dec; 24(4):207-214. Arjomandi M, Galanter JM, Choudhry S, Eng C, Hu D, Beckman K, Chapela R, Rodríguez-Santana JR, Rodríguez-Cintrón W, Ford J, Avila PC, Burchard EG. PMID: 22276228.
      View in: PubMed   Mentions:
    41. Secreted osteopontin is highly polymerized in human airways and fragmented in asthmatic airway secretions. PLoS One. 2011; 6(10):e25678. Arjomandi M, Frelinger J, Donde A, Wong H, Yellamilli A, Raymond W. PMID: 22031818.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    42. PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice. Thorax. 2011 Sep; 66(9):788-96. Goolaerts A, Lafargue M, Song Y, Miyazawa B, Arjomandi M, Carlès M, Roux J, Howard M, Parks DA, Iles KE, Pittet JF. PMID: 21768189.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    43. Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility. J Occup Environ Med. 2010 Jun; 52(6):647-52. Arjomandi M, Seward J, Gotway MB, Nishimura S, Fulton GP, Thundiyil J, King TE, Harber P, Balmes JR. PMID: 20523233.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Pulmonary function abnormalities in never-smoking flight attendants exposed to secondhand tobacco smoke in the aircraft cabin. J Occup Environ Med. 2009 Jun; 51(6):639-46. Arjomandi M, Haight T, Redberg R, Gold WM. PMID: 19448573.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    45. Is there an association between lifetime cumulative exposure and acute pulmonary responses to ozone? J Occup Environ Med. 2008 Mar; 50(3):341-9. Arjomandi M, Tager IB, Bastaki M, Chen C, Holland N, Balmes JR. PMID: 18332784.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    46. Effects of chronic and acute ozone exposure on lipid peroxidation and antioxidant capacity in healthy young adults. Environ Health Perspect. 2007 Dec; 115(12):1732-7. Chen C, Arjomandi M, Balmes J, Tager I, Holland N. PMID: 18087591.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCellsPHPublic Health
    47. Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes. Eur Respir J. 2007 Oct; 30(4):677-83. Chen C, Arjomandi M, Tager IB, Holland N, Balmes JR. PMID: 17652311.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    48. Cytogenetic damage in buccal epithelia and peripheral lymphocytes of young healthy individuals exposed to ozone. Mutagenesis. 2006 Mar; 21(2):131-7. Chen C, Arjomandi M, Qin H, Balmes J, Tager I, Holland N. PMID: 16513656.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    49. Effects of nitrogen dioxide on allergic airway responses in subjects with asthma. J Occup Environ Med. 2005 Dec; 47(12):1250-9. Witten A, Solomon C, Abbritti E, Arjomandi M, Zhai W, Kleinman M, Balmes J. PMID: 16340706.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    50. Sputum induction and bronchoscopy for assessment of ozone-induced airway inflammation in asthma. Chest. 2005 Jul; 128(1):416-23. Arjomandi M, Schmidlin I, Girling P, Boylen K, Ferrando R, Balmes J. PMID: 16002965.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    51. Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways. Am J Respir Crit Care Med. 2005 Aug 15; 172(4):427-32. Arjomandi M, Witten A, Abbritti E, Reintjes K, Schmidlin I, Zhai W, Solomon C, Balmes J. PMID: 15937293.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    52. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol. 1996 Nov 15; 28(6):1573-9. Wang BY, Candipan RC, Arjomandi M, Hsiun PT, Tsao PS, Cooke JP. PMID: 8917274.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    53. Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor. J Steroid Biochem Mol Biol. 1994 Jan; 48(1):101-10. Renoir JM, Le Bihan S, Mercier-Bodard C, Gold A, Arjomandi M, Radanyi C, Baulieu EE. PMID: 7510997.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    Mehrdad's Networks
    Concepts (218)
    Derived automatically from this person's publications.
    _
    Co-Authors (28)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _